November 30, 2024 - 01:41

Stocks finished off a winning month of November at record highs, capping a holiday-shortened trading session that left investors optimistic about the market's direction. The Dow Jones Industrial Average and the S&P 500 both closed at all-time highs, reflecting strong investor sentiment and robust economic indicators.
The surge in stock prices can be attributed to a combination of factors, including positive corporate earnings reports and encouraging economic data that suggest a resilient recovery. Investors have been buoyed by signs of consumer spending growth and a stable job market, which have contributed to a favorable outlook for many sectors.
As the year draws to a close, market analysts are closely watching the Federal Reserve's next moves regarding interest rates and inflation. Despite potential headwinds, the prevailing sentiment remains optimistic, with many believing that the momentum seen in November may carry into the upcoming months. The strong performance of the stock market serves as a testament to the resilience of the economy and the confidence of investors.
June 7, 2026 - 04:43
Why Pay More for Gold? GLDM Offers the Same Bullion for a Fraction of GLD's CostA 58-year-old investor with $100,000 parked in SPDR Gold Trust (GLD) as a crisis hedge is paying roughly $300 more per year than necessary for the exact same bars of bullion. That is the...
June 6, 2026 - 00:01
The Spill: Why Financial Pros Are Piling Into IWM Right NowAfter years of playing second fiddle to mega-cap tech stocks, small-cap equities are suddenly the center of attention. The iShares Russell 2000 ETF, known by its ticker IWM, is seeing a wave of...
June 5, 2026 - 04:07
Medallion Financial Corp. Exposes ZimCal’s Latest Campaign of Distortion and the Risks of Electing Its Unqualified NomineesMedallion Financial Corp. has issued a sharp rebuttal against ZimCal`s latest proxy fight, accusing the investment firm of running a campaign built on distortions and misaligned incentives. The...
June 4, 2026 - 04:31
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration DocumentOSE Immunotherapeutics SA announced its audited consolidated financial results for the full year 2025 on June 3, 2026. The company confirmed that the audited figures are consistent with the...